Deal Watch: Vir Partnering With Alnylam, WuXi On Coronavirus Treatments

05 Mar 2020

• By Joseph Haas, Ian Haydock, Jung Won Shin, Sten Stovall, and Mary Jo Laffler

US biotech expands 2017 collaboration with Alnylam and inks collaboration with WuXi. Plus deals involving AbbVie, Allergan, Amazon, Thermo Fisher, Qiagen, Boehringer Ingelheim, Trutino, Taiho, Arcus, Eisai, Fuji Yakuhin, Hikma, Glenmark, Hanmi, GC, Bayer, GW.

Deal Watch: Vir Partnering With Alnylam, WuXi On Coronavirus Treatments

More from Deals

More from Business